Abstract Background/Aims: Irritable bowel syndrome with diarrhoea (IBS-D) is a chronic, functional bowel disorder characterized by abdominal pain or diarrhoea and altered bowel habits, which correlate with intestinal hyperpermeability. MicroRNAs (miRNAs) are involved in regulating intestinal permeability in IBS-D. However, the role of miRNAs in regulating intestinal permeability and protecting the epithelial barrier remains unclear. Our goals were to (i) identify differential expression of miRNAs and their targets in the distal colon of IBS-D rats; (ii) verify in vitro whether occludin (OCLN) and zonula occludens 1 (ZO1/TJP1) were direct targets of miR-144 and were down-regulated in IBS-D rats; and (iii) determine whether down-regulation of miR-144 in vitro could reverse the pathological hallmarks of intestinal hyperpermeability via targeting OCLN and ZO1. Methods: The IBS-D rat model was established using 4% acetic acid and evaluated by haematoxylin-eosin (HE) staining. The distal colon was obtained in order to perform miRNA microarray analysis and to isolate and culture colonic epithelial cells. When differential expression of miRNA was found, the results were verified by qRT-PCR, and the target genes were further explored by bioinformatics analysis. Correlation analyses were carried out to compare the expression of miRNA and target genes. Then, mutants, miRNA mimics and inhibitors of the target genes were constructed and transfected to colonic epithelial cells. qRT-PCR, western blotting, enzyme-linked immunosorbent assays (ELISAs) and dual-luciferase assays were used to investigate the expression of miR-144 and OCLN, ZO1 in IBS-D rats. Results: There were 8 up-regulated and 18 down-regulated miRNAs identified in the IBS-D rat model. Of these, miR-144 was markedly up-regulated and resulted in the downregulation of OCLN and ZO1 expression. Overexpression of miR-144 by transfection of miR-144 precursor markedly inhibited the expression of OCLN and ZO1. Further studies confirmed 
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Introduction
Patients with irritable bowel syndrome with diarrhoea (IBS-D) always have intestinal hyperpermeability, which contributes to their diarrhoea and abdominal pain [1] . An intact intestinal barrier is essential to prevent the paracellular permeability of bacteria and toxic macromolecules from the gut lumen into the systemic circulation [2] . Disruption of the intestinal tight junctions may be a critical underlying pathophysiologic factor in patients with any of several inflammatory conditions, including coeliac disease [3] , inflammatory bowel disease [4] , food allergies [5] and type 1 diabetes [6] . The current understanding of the in vivo molecular mechanisms of increased intestinal permeability in patients with gastrointestinal disorders remains limited [7] . Thus, the identification of factors that regulate the intestinal permeability holds potential for identifying novel targets to prevent IBS-D.
MicroRNAs (miRNAs) are a large family of small (17-25 nucleotides), non-coding, singlestranded, endogenous RNAs that have been identified as regulators of biological processes [8] . miRNAs regulate gene expression by binding to the 3′ untranslated regions (3′ UTRs) of their target mRNAs via either promoting degradation of the target mRNAs or inhibiting their translation [9] . Bioinformatic studies [9, 10] have suggested that miRNAs may regulate one-third of the transcriptome, suggesting an essential role for miRNAs in regulating gene expression. Increasing evidence [11, 12] has demonstrated that miRNAs have critical functions in regulating cellular dysregulation and ultimately pathobiology. Recently, a growing body of results has suggested that miRNAs have important roles in malignancies [13] , infections [14] and chronic inflammatory disorders of the digestive tract [15] . However, the role of miRNAs in regulating and detecting changes in barrier permeability in IBS-D remains unclear.
In our study, we applied miR microarray profiling to screen the differential expression of miRNAs in the IBS-D rat model. We then identified miR-144 as highly expressed in this model. We also performed bioinformatic analysis using PicTar, TargetScan and microRNA.org, which ultimately allowed us to identify the genes OCLN (NM_002538) and ZO1 (NM_003257) as potential targets of miR-144. Our results provide novel insights into the role of miR-144 in IBS-D and provide a new therapeutic target to relieve symptoms arising from intestinal hyperpermeability.
Materials and Methods

Establishment of the IBS-D rat model
Forty (20 male and 20 female) Sprague-Dawley rats (4 weeks old, weighing 180±10 g) were purchased from the Guangzhou Experimental Animals Center (Guangzhou, China) and then randomly divided into two groups: the model group and the control group. The model group was treated with an intracolonic instillation of 1 mL of 4% acetic acid at 8 cm proximal to the anus for 30 s after being lightly anaesthetized with ether [16] . Then, 1 mL of phosphate-buffered saline (PBS) was instilled to dilute the acetic acid and flush the colon. The control group was handled identically, except that 1 mL of saline was instilled instead of 4% acetic acid. The rats were left to recover from colitis for 6 days. On the 7th day, the rats in the two groups were sacrificed. The distal colon of the rats was obtained and then stained with haematoxylin-eosin (HE). This study was approved by the Animal Experimentation Ethics Committee of Guangzhou University of Chinese Medicine, and all methods involved were carried out in accordance with the approved guidelines. 
miRNA microarray analysis
The distal colon of the two groups was used for the miRNA microarray assay, which was performed at Guangzhou RiboBio Co., Ltd. The assay consisted of four steps: prehybridization, hybridization, hybridization washing and imaging. The CustomArray™ microarray was assembled using a hybridization cap and clips, and then prehybridization was performed. The hybridization chambers were filled with nuclease-free water, incubated at 65 °C for 10 min, and then gradually reduced to room temperature. After the water was drawn out of the hybridization chamber, the chamber was filled with prehybridization solution, incubated at 37 °C for 60 minutes and gently rotated in the hybridization oven. Next, the hybridization was performed:
The hybridization solution was prepared according to the following procedure. The total RNA from the distal colon in the two groups was extracted using the TRIzol method and fluorescently labelled with Cy3 using the ULS TM (UNIVERSAL LINKAGE SYSTEM) protocol, and then the solution was denatured at 95 °C for 3 min and cooled on ice for 20 s to prepare for the hybridization steps. The hybridization chambers were filled with hybridization solution, followed by removal of the prehybridization solution, gentle mixing and incubation at 37 °C for 16 hours. Finally, the microarray was washed to reduce the specific hybridization background, covered with the imaging solution and loaded into the GenePix 4000B microarray scanner to scan.
Isolation and culture of colonic epithelial cells
The distal colons obtained from the model group were cut into small pieces, washed and digested with 0.1% collagenase I and hyaluronidase for 25 mins at 37 °C to separate the colonic epithelial cell clusters [17] . After digestion, the supernatant was transferred into a new tube, and Dulbecco's modified Eagle's medium (DMEM) was added. After centrifuging 3 times, cells were cultured in DMEM containing 100 mL/L foetal bovine serum in a CO 2 incubator with saturated humidity at 37 °C. Fibroblasts were removed using phase-difference digestion and adherence. When 80%-90% of the cells were adherent to culture plates, the cells were passaged by trypsin digestion.
RNA oligoribonucleotides, cell culture and transfection
The RNA oligoribonucleotides (miR-144 mimics, miR-144 inhibitor, mimic control, inhibitor control, si-OCLN and si-ZO1) used in this study were synthesized by Shanghai GenePharma Co., Ltd. (GenePharma Co., Ltd, Shanghai, China). Prior to transfection, colonic epithelial cells were isolated and seeded (2×10 6 cells/mL) into 6-well plates and grown until they were 60-80% confluent. The cells were then transfected with 100 nM miR-144 mimics, miR-144 inhibitor, mimic control, inhibitor control, si-OCLN and si-ZO1 for 6 h according to the protocol for Lipofectamine™ 2000 (Invitrogen, Carlsbad, CA, USA). The cells were then digested with 0.025% trypsin for 24 h and collected for further analyses: qRT-PCR, western blotting, enzyme-linked immunosorbent assays (ELISAs) and dual-luciferase assays. The cells from the IBS-D rat model that were transfected with mimic control were treated as the model group, while the cells from the normal rat transfected with nothing were treated as the control group.
Total RNA extraction and qRT-PCR Total RNA was extracted using a total RNA extraction kit (Omega, Norcross, GA, USA), according to the manufacturer's instructions. The expression levels of the mRNAs, including OCLN and ZO1, were verified by quantitative real-time PCR. Complementary DNA (cDNA) was synthesized using the RevertAid First Strand cDNA Kit (Thermo Fisher Scientific, Waltham, MA, USA). qRT-PCR was carried out using the Platinum SYBR Green qRT-PCR SuperMix-UDG Kit (Life Technologies) on an ABI Prism 7500 PCR system (Applied Biosystems, USA). The primers were designed as follows: OCLN, 5'-AAGACGATGAGGTGCAGAAG-3' (forward) and 5'-GTGAAGAGAGCCTGACCAAA-3' (reverse); ZO1, 5'-GGAGAGGTG TTTCGTGTTGT-3' (forward) and 5'-ACTGCTCAGCCCTGTTCTTA-3' (reverse); β-actin, 5'-CGTGACATTAAGGAGAAGCTG-3' (forward) and 5'-CTAGAAGCATTTGCGGTGGAC-3' (reverse). The relative expression was calculated using the 2 −∆Ct method. β-Actin was used as the internal reference to normalize the expression levels. Each experiment was performed in triplicate.
Western blotting
Proteins were extracted from the colonic epithelial cells from each group using RIPA buffer according to the manufacturer's instructions. A BCA Protein Assay Kit (Beyotime, Beijing, China) was used to determine Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry the protein concentrations. Equal amounts of proteins were loaded onto sodium dodecyl sulphatepolyacrylamide gels (SDS-PAGE) and transferred to polyvinylidene difluoride (PVDF) membranes. The membranes were incubated with primary antibodies overnight at 4 °C (1:300 dilution, monoclonal rat anti-OCLN, anti-ZO1 and anti-E-cadherin; Santa Cruz Biotechnology, Dallas, TX, USA), followed by incubation with a secondary antibody (1:3, 000 dilution, horseradish peroxidase-conjugated rabbit anti-rat IgG, Santa Cruz Biotechnology, Santa Cruz, USA) at 37 °C for 1 h. The blots were examined using a chemiluminescence detection kit (Amersham Pharmacia Biotech, Piscataway, NJ, USA). An antibody against β-actin (Santa Cruz Biotechnology, Santa Cruz, USA) served as an internal reference.
ELISAs
We determined the cellular contents of OCLN, ZO1 and E-cadherin in the culture supernatant. The colonic epithelial cells from the model group and control group were digested with 0.025% trypsin for 24 h, harvested at a density of approximately 1×10 6 cells/mL, and then seeded in 96-well plates without any treatment. On day 7 and day 14, the contents of OCLN, ZO1 and E-cadherin in the culture supernatant were determined using the appropriate ELISA kits (R&D Systems, Minneapolis, MN, USA) according to the manufacturer's instructions. Then, the concentrations of OCLN, ZO1 and E-cadherin were ascertained based on optical density (OD) values measured at 450 nm using a microplate reader. The experiment was repeated three times, and the average OD values were determined.
Dual-luciferase assay
The bioinformatics analysis suggested that OCLN and ZO1 were potential target genes of miR-144. The 3′ UTR fragments of both OCLN and ZO1 were PCR amplified from the human genome. The corresponding mutant fragments were amplified by overlap-extension PCR. Next, four different recombinant vectors were constructed and synthesized by Shanghai GenePharma Co., Ltd. (GenePharma Co., Ltd, Shanghai, China): pmirGLO-wt-OCLN, pmirGLO-mt-OCLN, pmirGLO-wt-ZO1, and pmirGLO-mt-ZO1. Using Lipofectamine™ 2000, the colonic epithelial cells were co-transfected with miRNAs (miR-144 mimics, miR-144 inhibitor, mimic control or inhibitor control) and reporter vectors (wild-type or mutant). A Dual-Luciferase Assay Kit (Promega, Madison, WI, USA) was used to detect the luciferase activity according to the manufacturer's instructions.
Rescue assays
The open reading frame (ORF) fragments of the OCLN and ZO1 genes without 3′ UTRs were amplified by PCR, and two recombinant vectors were constructed using the plasmid pcDNA 3.1 (Invitrogen, Carlsbad, CA, USA): pcDNA3.1-OCLN and pcDNA3.1-ZO1. Colonic epithelial cells were then separately transfected with pcDNA3.1-OCLN, pcDNA3.1-ZO1, and miR-144 mimics or co-transfected with the expression vectors and miR-144 mimics. Cells transfected without any plasmid were used as the control group. Western blotting and qRT-PCR were then used to detect the expression of OCLN and ZO1.
Statistical analyses SPSS 17.0 (SPSS Inc., Chicago, IL, USA) was used for the statistical analyses. The data are presented as the means ± standard deviation. One-way analysis of variance (ANOVA) and least significant difference (LSD) multiple comparison tests were used to compare the differences between the groups. Spearman's correlation coefficients were used to examine the correlation between OCLN, ZO1 and miR-144. Differences were regarded as statistically significant when P < 0.05. 
regulated in the model group compared with the control group (Fig. 1C ). Because the model group showed up-regulation of miR-144 and down-regulation of OCLN and ZO1, we next performed a correlation analysis, which showed that OCLN and ZO1 were both negatively correlated with miR-144 expression (Fig. 1D ).
OCLN and ZO1 were direct targets of miR-144
Bioinformatics analyses using TargetScan (http://www.targetscan.org/), PicTar (http://pictar.mdc-berlin.de/), and the tools at http://www.microrna.org/ found that the OCLN (NM_002538) and ZO1 (NM_003257) mRNAs contain a matching 3′ UTR sequence that targets the seed region of miR-144 ( Fig. 2A) , suggesting that OCLN and ZO1 are potential target genes of miR-144. We next transfected IBS-D rat colonic epithelial cells with miR-144 mimics, miR-144 inhibitor, mimic controls or inhibitor controls to detect the interaction between miR-144, OCLN and ZO1. Western blotting showed that compared with the relevant control groups, OCLN and ZO1 were down-regulated in the miR-144 mimic group and upregulated in the miR-144 inhibitor group (Fig. 2B) . Furthermore, the dual-luciferase assays showed significantly reduced luciferase activity in the IBS-D rat colonic epithelial cells that were co-transfected with miR-144 mimics and pmirGLO-wt-OCLN compared with the cells that were co-transfected with miR-144 mimics and pmirGLO-mt-OCLN. In addition, significantly enhanced luciferase activity was observed in the IBS-D rat colonic epithelial cells that were co-transfected with the miR-144 inhibitor and pmirGLO-wt-OCLN compared with the cells that were co-transfected with miR-144 inhibitor and pmirGLO-mt-OCLN. Similar results were observed for the IBS-D rat colonic epithelial cells that were co-transfected with miR-144 mimics and pmirGLO-wt-ZO1 compared with cells that were co-transfected with the miR-144 inhibitor and pmirGLO-wt-ZO1 (Fig. 2C, D) . These results indicate that miR-144 can bind to pmirGLO-wt-OCLN and pmirGLO-wt-ZO1 mRNAs and negatively regulate luciferase activity, implying that OCLN and ZO1 are potential targets of miR-144.
In IBS-D rats, intestinal permeability was enhanced, epithelial barrier function was inhibited and miR-144 was up-regulated
Next, the colonic epithelial cells from the model group were continuously evaluated for 14 days. ELISA performed on days 7 and 14 revealed significant decreases in the OCLN, ZO1, and E-cadherin contents of the IBS-D rat colonic epithelial cells from the model group compared with the control group (Fig. 3A, B, C) , suggesting that intestinal permeability was increased in IBS-D rats. We also examined the expression levels of OCLN, ZO1, and E-cadherin by western blotting (Fig. 3D ) and qRT-PCR (Fig. 3E, F, H) , and OCLN, ZO1, and E-cadherin were significantly down-regulated in the model group compared with the control group. These results support our findings of increased intestinal permeability and reduced epithelial barrier function in IBS-D rats. Moreover, the qRT-PCR results revealed that miR-144 was significantly up-regulated in the model group compared with the control group on day 7 and day 14 (Fig. 3I ). This result is in accordance with our miRNA microarray analysis and strongly suggests that miR-144 is involved in promoting the intestinal permeability in IBS-D rats.
Up-regulation of miR-144 promoted intestinal permeability and attenuated epithelial barrier function in IBS-D rats
We collected IBS-D rat colonic epithelial cells that overexpressed miR-144 (miR-144 group) to investigate the involvement of miR-144 in intestinal permeability and epithelial barrier function. The qRT-PCR results confirmed successful transfection, with significantly higher miR-144 expression in the miR-144 group than in the model and control groups (Fig.  4A) . Consistent with those observations, western blotting (Fig. 4B ) and qRT-PCR (Fig. 4C) showed that the expression of genes associated with intestinal permeability (OCLN, ZO1, and E-cadherin) were differentially expressed. OCLN, ZO1, and E-cadherin were significantly down-regulated. These results suggested that miR-144 up-regulation effectively promoted intestinal permeability and attenuated epithelial barrier function in IBS-D rats.
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Expression of OCLN and ZO1 without 3′ UTRs partially rescued the effects of miR-144 overexpression on the colonic epithelial cells of IBS-D rats
To further confirm that miR-144 promoted intestinal permeability and attenuated epithelial barrier function by targeting OCLN and ZO1, we next co-transfected IBS-D rat colonic epithelial cells with OCLN or ZO1 overexpression vectors that lacked the 3′ UTR. Transfections with pcDNA3.1-OCLN or pcDNA3.1-ZO1 were successful and led to significantly up-regulated expression of OCLN or ZO1, according to the western blotting results (Fig. 5A) . We then evaluated the mRNA expression of OCLN or ZO1 by qRT-PCR. A significant increase in the OCLN content was detected in the cells that were transfected with pcDNA3.1-OCLN alone compared with the cells that were co-transfected with pcDNA3.1-OCLN and miR-144. Similarly, increased ZO1 content was detected in the cells that were transfected with pcDNA3.1-ZO1 alone compared with the cells that were co-transfected with pcDNA3.1-ZO1 and miR-144 (Fig. 5B) . These results showed that the expression of OCLN and ZO1 without 3′ UTRs could partially rescue the effects of miR-144 overexpression.
Intestinal permeability in IBS-D rats was more strongly promoted by up-regulation of miR-144 than by si-OCLN or si-ZO1
We transfected IBS-D rat colonic epithelial cells with miR-144, si-OCLN, and si-ZO1 to compare the effects of these constructs on the intestinal permeability and epithelial barrier function. Successful transfection was verified by qRT-PCR (Fig. 6A) . Next, we examined the proteins and genes associated with intestinal permeability and epithelial barrier function. The western blotting (Fig. 6B ) and qRT-PCR (Fig. 6C ) results showed significantly reduced Cell
expression of OCLN, ZO1 and E-cadherin in the miR-144, si-OCN1 and si-ZO1 groups compared with the model, and miR-144 had the strongest effect. Overall, miR-144 upregulation showed a stronger effect on promoting intestinal permeability and attenuating epithelial barrier function in IBS-D rats than si-OCLN or si-ZO1. HE staining revealed the dilated intercellular space of the colonic epithelial cells in the miR-144 group compared to the model, si-OCLN and si-ZO1 groups (Fig. 5D) . These results suggest that in IBS-D rats, miR-144 had a stronger effect on promoting intestinal permeability and attenuating epithelial barrier function than si-OCLN or si-ZO1.
Discussion
In recent years, emerging studies have shown that miRNAs are involved in regulating the gene expression of critical biologic processes [18] [19] [20] . miRNAs are a class of small (21-23 nucleotides long), single-stranded, non-coding RNAs that are distributed in diverse tissues and participate in various biological activities in eukaryotes [21] . miRNAs down-regulate target genes by either promoting mRNA degradation or inhibiting their translation and play significant roles in cell proliferation and differentiation [19] . miRNAs, such as miR-29, have previously been shown to be involved in regulating intestinal permeability [22] . Moreover, altered miRNA expression has been associated with the pathologic hallmarks of increased intestinal permeability. Therefore, to shed light on disease pathogenesis and to develop novel and effective therapeutic approaches, it is important to identify specific miRNAs and target genes that are involved in regulating intestinal permeability. Here, we identified 26 differentially expressed miRNAs in the intestinal tract of IBS-D rats. As described in detail in the Methods section, among the 26 differentiated expressed miRNAs, miR-144 was up-regulated, and subsequent bioinformatics analysis showed that miR-144 had a close interaction with OCLN and ZO1, which prompted us to further assess miR-144 and its role in intestinal permeability. OCLN is a key tight junction protein that interacts with intracellular signalling pathways that regulate and maintain intestinal permeability [23] . This factor strongly strengthens barrier integrity and inhibits intestinal permeability. Our research has shown that OCLN expression is significantly down-regulated in IBS-D rats, which is consistent with a previous study showing that decreased OCLN leads to increased intestinal permeability in IBS patients [22] . Thus, OCLN may be a key gene that can enhance epithelial barrier function and decrease paracellular permeability to macromolecules.
The other target gene identified was ZO1, another tight junction protein, which could enhance the colonic paracellular permeability in IBS patients [24] . Because ZO1 plays a vital role in tight junctions to maintain their appropriate structure and function, inhibition of its function might cause intestinal epithelial barrier dysfunction. Indeed, studies have shown that ZO1 overexpression could significantly stabilize the intestinal barrier function, whereas the administration of a ZO1-specific siRNA could break the integrity and promote the permeability of the intestinal mucosa [25] [26] [27] . Moreover, transgenic mice overexpressing ZO1 could reverse the intestinal hyperpermeability produced by ZO1 siRNA and represent an innovative approach to treating patients with increased intestinal permeability [28] .
Because the intestinal tract in IBS-D rats could simulate determination in vivo, we further examined miR-144 function in intestinal tract cells isolated from IBS-D rats by using Lipofectamine™ 2000 to transfect them with miR-144 mimics (details in the Methods section). Here, we found that miR-144 up-regulation increased intestinal permeability and suppressed epithelial barrier function by inhibiting OCLN and ZO1 in the intestinal tract of IBS-D rats. Together, these results indicated that miR-144 may serve as a factor promoting the progression of IBS-D. Further analysis showed that there was a negative correlation between miR-144, OCLN, and ZO1. Considering the characteristics of the miRNA function, we hypothesized that the role of miR-144 in IBS-D was mediated by the interactive endogenous relationship between miR-144, OCLN and ZO1. Indeed, the detailed regulatory pathways of these genes still require further investigation. Compared with the siRNAs targeting OCLN and ZO1, miR-144 showed a stronger effect in terms of comprehensively regulating the intestinal epithelial barrier dysfunction and stabilizing the intestinal barrier function. These results show that by targeting OCLN and ZO1, miR-144 regulates the integrity and permeability of the intestinal mucosa, which serves as a potent regulator for intestinal epithelial barrier function in IBS-D.
Bioinformatics analysis using PicTar, TargetScan and tools at microrna.org identified miR-144 as being associated with the permeability of epithelial cells; however, there is no evidence that shows that other miRNAs do not play a role in IBS-D. It has been reported that differential expression of several miRNAs may be correlated with inflammation [29] , peripheral circulation [30] , immunomodulatory [31] , gut microbiota [32] , and other processes that are involved in the pathogenesis of IBS-D. For example, Bitar [31] found that miR-155 was expressed in the duodenal epithelium at the acute stage of cholera and could limit the innate immune response of the host, including the inflammation evoked by its own secreted factors. Mansour's research [32] showed that decreased expression of miR-199b would lead to an increased coliform count. Furthermore, a recent study [33] showed that miR-16 and miR-125b are involved in barrier function dysregulation through the modulation of claudin-2 and cingulin expression in the jejunum in IBS with diarrhoea, which is similar to our research.
Conclusion
We identified 8 up-regulated and 18 down-regulated miRNAs in the intestinal tract of IBS-D rats. In particular, miR-144 was up-regulated. Moreover, miR-144 up-regulation 
